Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CorMedix Inc. before investing.

In this article, we go over a few key elements for understanding CorMedix Inc.’s stock price such as:

• CorMedix Inc.’s current stock price and volume
• Why CorMedix Inc.’s stock price changed recently
• Upgrades and downgrades for CRMD from analysts
• CRMD’s stock price momentum as measured by its relative strength

About CorMedix Inc. (CRMD)

Before we jump into CorMedix Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Want to learn more about CorMedix Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CorMedix Inc..

CorMedix Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, CorMedix Inc.’s stock price was $7.530.

CorMedix Inc. is up 0.53% from its previous closing price of $7.490.

During the last market session, CorMedix Inc.’s stock traded between $7.300 and $7.550. Currently, there are approximately 79.51 million shares outstanding for CorMedix Inc..

CorMedix Inc.’s price-earnings (P/E) ratio is currently at 3.6, which is low compared to the Pharmaceuticals industry median of 20.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

CorMedix Inc. Stock Price History

CorMedix Inc.’s (CRMD) price is currently down 4.08% so far this month.

During the month of July, CorMedix Inc.’s stock price has reached a high of $8.980 and a low of $7.130.

Over the last year, CorMedix Inc. has hit prices as high as $14.960 and as low as $6.125. Year to date, CorMedix Inc.’s stock is down 35.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused CorMedix Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded CorMedix Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate CorMedix Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CorMedix Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

CorMedix Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CorMedix Inc. (CRMD) by visiting AAII Stock Evaluator.

Relative Price Strength of CorMedix Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, CorMedix Inc. has a weighted four-quarter relative price strength of -12.00%, which translates to a Momentum Score of 21 and is considered to be Weak.

Want to learn more about how CorMedix Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

CorMedix Inc. Stock Price: Bottom Line

As of July 31, 2026, CorMedix Inc.’s stock price is $7.530, which is up 0.53% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CorMedix Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.